EyePoint Pharmaceuticals (EYPT) Retained Earnings: 2011-2018
Historic Retained Earnings for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Jun 2018 value amounting to -$364.0 million.
- EyePoint Pharmaceuticals' Retained Earnings fell 29.79% to -$427.7 million in Q1 2019 from the same period last year, while for Mar 2019 it was -$427.7 million, marking a year-over-year decrease of 29.79%. This contributed to the annual value of -$364.0 million for FY2018, which is 17.11% down from last year.
- According to the latest figures from FY2018, EyePoint Pharmaceuticals' Retained Earnings is -$364.0 million, which was down 17.11% from -$310.8 million recorded in FY2017.
- Over the past 5 years, EyePoint Pharmaceuticals' Retained Earnings peaked at -$270.7 million during FY2015, and registered a low of -$364.0 million during FY2018.
- Moreover, its 3-year median value for Retained Earnings was -$310.8 million (2017), whereas its average is -$322.3 million.
- Per our database at Business Quant, EyePoint Pharmaceuticals' Retained Earnings increased by 2.29% in 2015 and then declined by 17.11% in 2018.
- EyePoint Pharmaceuticals' Retained Earnings (Yearly) stood at -$277.0 million in 2014, then increased by 2.29% to -$270.7 million in 2015, then dropped by 7.96% to -$292.2 million in 2016, then decreased by 6.37% to -$310.8 million in 2017, then declined by 17.11% to -$364.0 million in 2018.